Literature DB >> 32098546

Clinical relevance of understanding mitogen-activated protein kinases involved in asthma.

Corrado Pelaia1, Alessandro Vatrella2, Claudia Crimi3, Luca Gallelli4, Rosa Terracciano4, Girolamo Pelaia1.   

Abstract

Introduction: Mitogen-activated protein kinases (MAPKs) are a large family of evolutionary conserved intracellular enzymes that play a pivotal role in signaling pathways mediating the biologic actions of a wide array of extracellular stimuli.Areas covered: MAPKs are implicated in most pathogenic events involved in asthma, including both inflammatory and structural changes occurring in the airways. Indeed, MAPKs are located at the level of crucial convergence points within the signal transduction networks activated by many cytokines, chemokines, growth factors, and other inducers of bronchial inflammation and remodeling such as immunoglobulin E (IgE) and oxidative stress.Expert opinion: Therefore, given the growing importance of MAPKs in asthma pathobiology, these signaling enzymes are emerging as key intracellular pathways whose upstream activation can be inhibited by biological drugs such as anti-cytokines and anti-IgE.

Entities:  

Keywords:  Asthma; ERK; JNK; MAPK inhibitors; MAPKs; p38

Mesh:

Substances:

Year:  2020        PMID: 32098546     DOI: 10.1080/17476348.2020.1735365

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  8 in total

1.  MAP2K2 Delays Recovery in Murine Models of Acute Lung Injury and Associates with Acute Respiratory Distress Syndrome Outcome.

Authors:  Ke-Qin Gong; Carmen Mikacenic; Matthew E Long; Charles W Frevert; Timothy P Birkland; Jean Charron; Sina A Gharib; Anne M Manicone
Journal:  Am J Respir Cell Mol Biol       Date:  2022-05       Impact factor: 7.748

2.  Mechanism of Peitu Shengjin Formula Shenlingbaizhu Powder in Treating Bronchial Asthma and Allergic Colitis through Different Diseases with Simultaneous Treatment Based on Network Pharmacology and Molecular Docking.

Authors:  Liying Zeng; Shaodan Sun; Peiwen Chen; Qina Ye; Xiaoling Lin; Hongjun Wan; Yawen Cai; Xiaogang Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-09       Impact factor: 2.650

3.  Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression.

Authors:  Corrado Pelaia; Claudia Crimi; Alida Benfante; Maria Filomena Caiaffa; Cecilia Calabrese; Giovanna Elisiana Carpagnano; Domenico Ciotta; Maria D'Amato; Luigi Macchia; Santi Nolasco; Girolamo Pelaia; Simona Pellegrino; Nicola Scichilone; Giulia Scioscia; Giuseppe Spadaro; Giuseppe Valenti; Alessandro Vatrella; Nunzio Crimi
Journal:  J Asthma Allergy       Date:  2021-02-22

Review 4.  Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies.

Authors:  Corrado Pelaia; Alessandro Vatrella; Luca Gallelli; Nicola Lombardo; Angela Sciacqua; Rocco Savino; Girolamo Pelaia
Journal:  Drug Des Devel Ther       Date:  2021-03-23       Impact factor: 4.162

5.  Solid lipid nanoparticle delivery of rhynchophylline enhanced the efficiency of allergic asthma treatment via the upregulation of suppressor of cytokine signaling 1 by repressing the p38 signaling pathway.

Authors:  Chuanfeng Lv; Hui Li; Hongxia Cui; Qianyu Bi; Meng Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Exploration in the Mechanism of Zhisou San for the Treatment of Cough Variant Asthma Based on Network Pharmacology.

Authors:  De-Hai Guo; Jin-Ping Hao; Xing-Jie Li; Qing Miao; Qiong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-29       Impact factor: 2.650

7.  Identification of potential biomarkers and pathogenesis in neutrophil-predominant severe asthma: A comprehensive bioinformatics analysis.

Authors:  Shuanglan Xu; Zi Chen; Linyang Ge; Chenhui Ma; Quan He; Weihua Liu; Liuchao Zhang; Linfu Zhou
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

8.  Canavalia gladiata Pod Extract Mitigates Ovalbumin-Induced Asthma Onset in Male BALB/c Mice via Suppression of MAPK.

Authors:  Wen Yan Huang; Sang Hoon Lee; Seong Ju Oh; Hyeock Yoon; Jeong Hoon Pan; Inhye Jeong; Mi Jeong Kim; Bok Kyung Han; Jae Kyeom Kim; Eui-Cheol Shin; Young Jun Kim
Journal:  Molecules       Date:  2022-09-25       Impact factor: 4.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.